Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2012
08/09/2012US20120202773 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202764 Low molecular weight pharmacological activity modulators
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202744 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120201896 Biologic replacement for fibrin clot
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201870 Dicalcium Phosphate Ceramics, Dicalcium Phosphate/Hydroxyapatite Biphasic Ceramics and Method of Manufacturing the Same
08/09/2012US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
08/09/2012US20120201835 Antibodies specific for dkk-1
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201827 Anti-cd38 antibodies
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201815 Methods of altering bone growth by administration of sost or wise antagonist or agonist
08/09/2012US20120201812 Stable formulations of polypeptides and uses thereof
08/09/2012US20120201803 3-substituted compounds for reducing uric acid
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201781 Treatment of osteoarthritis and pain
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012CA2826356A1 Substance for preventing and improving arthritis
08/09/2012CA2826166A1 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
08/09/2012CA2824089A1 Selection and treatment of subjects
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484679A2 N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484372A1 Activin-ActRIIa Antagonists and Uses for Promoting Bone Growth in Cancer Patients
08/08/2012EP2484348A2 Pharmaceutical composition for treating and preventing diseases involving joints and connective tissue
08/08/2012EP2483300A1 Synthetic myostatin peptide antagonists
08/08/2012EP2482823A2 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2152753B1 Antibodies against ramp3
08/08/2012EP2124997B1 Use of il-1 antagonists to treat gout and pseudogout
08/08/2012EP2054050B1 Treatment of cartilage disorders with fgf-18
08/08/2012EP1869031B1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
08/08/2012EP1817276B1 Cathepsin cysteine protease inhibitors
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102630227A Bisphosphonate compounds for treating bone metabolism disorders
08/08/2012CN102630157A Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium
08/08/2012CN102627686A Polypeptide with effect of inhibiting activity of fibroblast growth factor receptor 3 and application thereof
08/08/2012CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents
08/08/2012CN102627578A Phenyl benzylamine compound and application thereof
08/08/2012CN102626522A Polypeptide radioactive diagnosis and treatment medicament based on chemotactic factor receptor CXCR4 polypeptide antagonist
08/08/2012CN102626505A Massaging paste based on Chinese medicinal herbs and preparation method thereof
08/08/2012CN102626501A Method for preparing health-care ointment for bone recovering
08/08/2012CN102626496A Traditional Chinese medicine for treating diabetic gout
08/08/2012CN102626491A Externally used Chinese herbal medicine composition for treatment of lumbar interveterbral disc protrusion
08/08/2012CN102626479A External-use Chinese herbal medicine composition for chronic rheumatism treatment
08/08/2012CN102626463A Natural medicine compound for increasing bone mineral density and preventing and treating osteoporosis
08/08/2012CN102626444A Medicine combination for treating gout and preparing method and application thereof
08/08/2012CN102626443A Chinese herbal medicine combination for treating gout
08/08/2012CN102626423A Compound preparation containing heptaene menadione and application thereof
08/08/2012CN102626420A Mixed preparation containing strontium, calcium and vitamin D
08/08/2012CN102626400A Oral sustained-release Anemone flaccida Fr. Schmidt saponin W3 capsule and preparation method thereof
08/08/2012CN102626387A Clopidogrel bisulfate liposome solid preparation
08/08/2012CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
08/08/2012CN102188692B Bone peptide composition, preparation thereof, preparation method thereof and application
08/08/2012CN102000047B Antrodia camphorata cyclonene compound for restraining growth of bone cancer cells
08/08/2012CN101961418B Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch
08/08/2012CN101941959B Application of dihydroxy-benzopyrone compounds in preparing medicaments for preventing and treating bone fracture and osteoporosis
08/08/2012CN101935363B Method for producing pharmaceutical grade hyaluronic acid
08/08/2012CN101912575B External medicament for treating painful swelling of joints and gout diseases and preparation process thereof
08/08/2012CN101594859B Compositions comprising carnosic acid 12-methylether
08/08/2012CN101590184B Traditional Chinese medicine combination for treating gout and preparation method thereof
08/08/2012CN101478934B Bioengineered intervertebral discs and methods for their preparation
08/08/2012CN101389342B Therapeutic agent for degenerative arthritis
08/08/2012CN101374529B Method of stabilizing s-adenosyl-l-methionine and stabilized composition
08/08/2012CN101148642B Probiotic/non-probiotic combinations
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236810 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012US8236784 Composition comprising threitol phosphate and salts thereof
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/02/2012WO2012102861A1 Polymer - active agent conjugates
08/02/2012WO2012102405A1 Ring-fused compound
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101263A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012WO2012101218A1 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
08/02/2012WO2012101173A1 N-methyl-2-pyrrolidone for prevention and treatment of bone loss
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012100734A1 Compounds useful as retinoid-related orphan receptor gamma modulators
08/02/2012WO2012100598A1 Early-stage rheumatoid arthritis specific antigen peroxiredoxin iv
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012078593A3 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
08/02/2012WO2012048291A3 Compositions and methods for inhibition of mmp:mmp-substrate interactions
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196919 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 820